Biliary Excretion Noted on Hepatobiliary Iminodiacetic Acid Scan Does Not Exclude Diagnosis of Biliary Atresia

Adebowale Adeyemi1, Lisa States2, Leslie Wann3

  • 1Division of Gastroenterology, Hepatology and Nutrition, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

Insights

Hepatobiliary iminodiacetic acid (HIDA) scans can misdiagnose biliary atresia in infants. Misinterpreted scans delay crucial surgical intervention for this serious liver condition.

Area of Science:

  • Pediatric Gastroenterology
  • Diagnostic Imaging
  • Hepatology

Background:

  • Biliary atresia is a severe neonatal liver disease requiring timely surgical intervention.
  • Hepatobiliary iminodiacetic acid (HIDA) scans are commonly employed to assess for biliary patency in cholestatic infants.
  • Accurate diagnosis is critical to prevent irreversible liver damage.

Observation:

  • This study reviewed 6 cases of infants with confirmed biliary atresia.
  • All infants in the study initially showed reported biliary patency on HIDA scans.
  • These findings highlight a potential discrepancy in HIDA scan interpretation.

Findings:

  • Misinterpretation of HIDA scans occurred in infants later diagnosed with biliary atresia.
  • False-negative HIDA scan results can mask the presence of biliary atresia.
  • Diagnostic errors led to significant delays in surgical management.

Implications:

  • Delayed diagnosis of biliary atresia can negatively impact surgical outcomes.
  • There is a critical need for improved HIDA scan interpretation protocols in pediatric cholestasis.
  • Enhanced diagnostic accuracy is essential for optimizing treatment for infants with biliary atresia.